skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 538  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Codon optimization and improved delivery/immunization regimen enhance the immune response against wild-type and drug-resistant HIV-1 reverse transcriptase, preserving its Th2-polarity
Codon optimization and improved delivery/immunization regimen enhance the immune response against wild-type and drug-resistant HIV-1 reverse transcriptase, preserving its Th2-polarity
Material Type:
Article 		Add to My Research

Codon optimization and improved delivery/immunization regimen enhance the immune response against wild-type and drug-resistant HIV-1 reverse transcriptase, preserving its Th2-polarity

Scientific reports, 2018-05, Vol.8 (1), p.8078-22, Article 8078 [Peer Reviewed Journal]

2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-018-26281-z ;PMID: 29799015

Full text available

Citations Cited by
2
Immunization with HIV-1 envelope T20-encoding DNA vaccines elicits cross-clade neutralizing antibody responses
Immunization with HIV-1 envelope T20-encoding DNA vaccines elicits cross-clade neutralizing antibody responses
Material Type:
Article 		Add to My Research

Immunization with HIV-1 envelope T20-encoding DNA vaccines elicits cross-clade neutralizing antibody responses

Human vaccines & immunotherapeutics, 2017-12, Vol.13 (12), p.2849-2858 [Peer Reviewed Journal]

2017 The Author(s). Published with license by Taylor & Francis © S. Stenler, K. E. Lundin, L. Hansen, S. Petkov, N. Mozafari, M. Isaguliants, P. Blomberg, C. I. E. Smith, D. M. Goldenberg, C.-H. Chang, K. Ljungberg, J. Hinkula, and B. Wahren 2017 ;2017 The Author(s). Published with license by Taylor & Francis 2017 The Author(s) ;ISSN: 2164-5515 ;ISSN: 2164-554X ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2017.1338546 ;PMID: 28696158

Full text available

Citations Cited by
3
DNA–VLP prime–boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity
DNA–VLP prime–boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity
Material Type:
Article 		Add to My Research

DNA–VLP prime–boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity

Vaccine, 2007-08, Vol.25 (32), p.5968-5977 [Peer Reviewed Journal]

Elsevier Ltd ;2007 Elsevier Ltd ;2007 INIST-CNRS ;Copyright Elsevier Limited Aug 10, 2007 ;ISSN: 0264-410X ;ISSN: 1873-2518 ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2007.05.052 ;PMID: 17629365 ;CODEN: VACCDE

Full text available

Citations Cited by
4
Amplified antigen-specific immune responses in HIV-1 infected individuals in a double blind DNA immunization and therapy interruption trial
Amplified antigen-specific immune responses in HIV-1 infected individuals in a double blind DNA immunization and therapy interruption trial
Material Type:
Article 		Add to My Research

Amplified antigen-specific immune responses in HIV-1 infected individuals in a double blind DNA immunization and therapy interruption trial

Vaccine, 2011-07, Vol.29 (33), p.5558-5566 [Peer Reviewed Journal]

2011 ;2015 INIST-CNRS ;Copyright © 2011. Published by Elsevier Ltd. ;Copyright Elsevier Limited Jul 26, 2011 ;ISSN: 0264-410X ;ISSN: 1873-2518 ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2011.01.064 ;PMID: 21300092 ;CODEN: VACCDE

Full text available

Citations Cited by
5
The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children
The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children
Material Type:
Article 		Add to My Research

The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children

Journal of Virus Eradication, 2015-07, Vol.1 (3), p.134-139 [Peer Reviewed Journal]

2015 The Authors.   published by Mediscript Ltd ;ISSN: 2055-6640 ;EISSN: 2055-6659 ;DOI: 10.1016/S2055-6640(20)30510-0 ;PMID: 26893908

Full text available

Citations Cited by
6
HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV
HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV
Material Type:
Article 		Add to My Research

HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV

Heliyon, 2017-06, Vol.3 (6), p.e00339-e00339, Article e00339 [Peer Reviewed Journal]

2017 The Authors ;2017 The Authors 2017 ;ISSN: 2405-8440 ;EISSN: 2405-8440 ;DOI: 10.1016/j.heliyon.2017.e00339 ;PMID: 28721397

Full text available

Citations Cited by
7
Enhancement of epitope-specific cellular immune responses by immunization with HIV-1 peptides genetically conjugated to the B-subunit of recombinant cholera toxin
Enhancement of epitope-specific cellular immune responses by immunization with HIV-1 peptides genetically conjugated to the B-subunit of recombinant cholera toxin
Material Type:
Article 		Add to My Research

Enhancement of epitope-specific cellular immune responses by immunization with HIV-1 peptides genetically conjugated to the B-subunit of recombinant cholera toxin

Vaccine, 2008-09, Vol.26 (40), p.5079-5082 [Peer Reviewed Journal]

Elsevier Ltd ;2008 Elsevier Ltd ;2008 INIST-CNRS ;Copyright Elsevier Limited Sep 19, 2008 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2008.03.096 ;PMID: 18514370 ;CODEN: VACCDE

Full text available

Citations Cited by
8
Micro-minicircle Gene Therapy: Implications of Size on Fermentation, Complexation, Shearing Resistance, and Expression
Micro-minicircle Gene Therapy: Implications of Size on Fermentation, Complexation, Shearing Resistance, and Expression
Material Type:
Article 		Add to My Research

Micro-minicircle Gene Therapy: Implications of Size on Fermentation, Complexation, Shearing Resistance, and Expression

Molecular therapy. Nucleic acids, 2014-01, Vol.3 (1), p.e140-e140, Article e140 [Peer Reviewed Journal]

2014 The American Society of Gene & Cell Therapy ;Copyright Nature Publishing Group Jan 2014 ;Copyright © 2014 The American Society of Gene & Cell Therapy 2014 The American Society of Gene & Cell Therapy ;ISSN: 2162-2531 ;EISSN: 2162-2531 ;DOI: 10.1038/mtna.2013.67 ;PMID: 24399204

Full text available

Citations Cited by
9
Cross-clade immune responses to Gag p24 in patients infected with different HIV-1 subtypes and correlation with HLA class I and II alleles
Cross-clade immune responses to Gag p24 in patients infected with different HIV-1 subtypes and correlation with HLA class I and II alleles
Material Type:
Article 		Add to My Research

Cross-clade immune responses to Gag p24 in patients infected with different HIV-1 subtypes and correlation with HLA class I and II alleles

Vaccine, 2008-09, Vol.26 (40), p.5182-5187 [Peer Reviewed Journal]

Elsevier Ltd ;2008 Elsevier Ltd ;2008 INIST-CNRS ;Copyright Elsevier Limited Sep 19, 2008 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2008.03.094 ;PMID: 18479789 ;CODEN: VACCDE

Full text available

Citations Cited by
10
Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HIV antibodies
Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HIV antibodies
Material Type:
Article 		Add to My Research

Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HIV antibodies

Gene therapy, 2004-07, Vol.11 (14), p.1146-1154 [Peer Reviewed Journal]

2004 INIST-CNRS ;COPYRIGHT 2004 Nature Publishing Group ;Copyright Nature Publishing Group Jul 2004 ;Springer Nature Limited 2004. ;ISSN: 0969-7128 ;EISSN: 1476-5462 ;DOI: 10.1038/sj.gt.3302275 ;PMID: 15103320

Full text available

Citations Cited by
11
P19-29. Determining the optimal protocol for plasmid DNA vaccine delivery by intradermal in vivo electroporation
P19-29. Determining the optimal protocol for plasmid DNA vaccine delivery by intradermal in vivo electroporation
Material Type:
Article 		Add to My Research

P19-29. Determining the optimal protocol for plasmid DNA vaccine delivery by intradermal in vivo electroporation

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.P349-P349, Article P349 [Peer Reviewed Journal]

Copyright © 2009 Hallengärd et al; licensee BioMed Central Ltd. 2009 Hallengärd et al; licensee BioMed Central Ltd. ;ISSN: 1742-4690 ;EISSN: 1742-4690 ;DOI: 10.1186/1742-4690-6-S3-P349

Full text available

Citations Cited by
12
HIV in Europe — a growing threat
HIV in Europe — a growing threat
Material Type:
Article 		Add to My Research

HIV in Europe — a growing threat

Journal of clinical virology, 2001-05, Vol.21 (2), p.171-173 [Peer Reviewed Journal]

2001 Elsevier Science B.V. ;ISSN: 1386-6532 ;EISSN: 1873-5967 ;DOI: 10.1016/S1386-6532(01)00162-7 ;PMID: 11417524

Full text available

Citations Cited by
13
Antibody-mediated inhibition of HIV-1 elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults
Antibody-mediated inhibition of HIV-1 elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults
Material Type:
Article 		Add to My Research

Antibody-mediated inhibition of HIV-1 elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults

RETROVIROLOGY, 2012-09, Vol.9 (S2), p.O53-O53, Article O53 [Peer Reviewed Journal]

2012 Joachim et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright ©2012 Joachim et al; licensee BioMed Central Ltd. 2012 Joachim et al; licensee BioMed Central Ltd. ;ISSN: 1742-4690 ;EISSN: 1742-4690 ;DOI: 10.1186/1742-4690-9-S2-O53

Full text available

Citations Cited by
14
Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen
Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen
Material Type:
Article 		Add to My Research

Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen

Journal of general virology, 2004-08, Vol.85 (8), p.2407-2419 [Peer Reviewed Journal]

2004 INIST-CNRS ;ISSN: 0022-1317 ;EISSN: 1465-2099 ;DOI: 10.1099/vir.0.79869-0 ;PMID: 15269383 ;CODEN: JGVIAY

Full text available

Citations Cited by
15
OA04-02. Strong HIV-specific CD4 and CD8 T-lymphocyte proliferation in HIV-1 DNA prime/modified vaccinia virus Ankara (MVA) heterologous boost vaccinees
OA04-02. Strong HIV-specific CD4 and CD8 T-lymphocyte proliferation in HIV-1 DNA prime/modified vaccinia virus Ankara (MVA) heterologous boost vaccinees
Material Type:
Article 		Add to My Research

OA04-02. Strong HIV-specific CD4 and CD8 T-lymphocyte proliferation in HIV-1 DNA prime/modified vaccinia virus Ankara (MVA) heterologous boost vaccinees

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.O26-O26, Article O26 [Peer Reviewed Journal]

Copyright © 2009 Nilsson et al; licensee BioMed Central Ltd. 2009 Nilsson et al; licensee BioMed Central Ltd. ;ISSN: 1742-4690 ;EISSN: 1742-4690 ;DOI: 10.1186/1742-4690-6-S3-O26

Full text available

Citations Cited by
16
The rationale behind a vaccine based on multiple HIV antigens
The rationale behind a vaccine based on multiple HIV antigens
Material Type:
Article 		Add to My Research

The rationale behind a vaccine based on multiple HIV antigens

Microbes and infection, 2005-11, Vol.7 (14), p.1414 [Peer Reviewed Journal]

ISSN: 1286-4579 ;EISSN: 1769-714X ;DOI: 10.1016/j.micinf.2005.07.017

Digital Resources/Online E-Resources

Citations Cited by
17
Pre-clinical Evaluation of a CEA DNA Prime/protein Boost Vaccination Strategy Against Colorectal Cancer
Pre-clinical Evaluation of a CEA DNA Prime/protein Boost Vaccination Strategy Against Colorectal Cancer
Material Type:
Article 		Add to My Research

Pre-clinical Evaluation of a CEA DNA Prime/protein Boost Vaccination Strategy Against Colorectal Cancer

Scandinavian journal of immunology, 2007-07, Vol.66 (1), p.43-51 [Peer Reviewed Journal]

ISSN: 0300-9475 ;EISSN: 1365-3083 ;DOI: 10.1111/j.1365-3083.2007.01945.x ;PMID: 17587345

Full text available

Citations Cited by
18
Priming with a “simplified regimen” of HIV-1 DNA vaccine is as good as a “standard regimen” when boosted with heterologous HIV-1 MVA vaccine
Priming with a “simplified regimen” of HIV-1 DNA vaccine is as good as a “standard regimen” when boosted with heterologous HIV-1 MVA vaccine
Material Type:
Article 		Add to My Research

Priming with a “simplified regimen” of HIV-1 DNA vaccine is as good as a “standard regimen” when boosted with heterologous HIV-1 MVA vaccine

RETROVIROLOGY, 2012-09, Vol.9 (S2), p.P108-P108, Article P108 [Peer Reviewed Journal]

2012 Munseri et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright ©2012 Munseri et al; licensee BioMed Central Ltd. 2012 Munseri et al; licensee BioMed Central Ltd. ;ISSN: 1742-4690 ;EISSN: 1742-4690 ;DOI: 10.1186/1742-4690-9-S2-P108

Full text available

Citations Cited by
19
Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime
Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime
Material Type:
Article 		Add to My Research

Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime

RETROVIROLOGY, 2012-09, Vol.9 (S2), p.P330-P330, Article P330 [Peer Reviewed Journal]

2012 Bauer et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright ©2012 Bauer et al; licensee BioMed Central Ltd. 2012 Bauer et al; licensee BioMed Central Ltd. ;ISSN: 1742-4690 ;EISSN: 1742-4690 ;DOI: 10.1186/1742-4690-9-S2-P330

Full text available

Citations Cited by
20
Breadth, phenotype and functionality of Gag-specific T cell responses induced by a heterologous DNA/MVA prime-boost HIV-1 vaccine regimen
Breadth, phenotype and functionality of Gag-specific T cell responses induced by a heterologous DNA/MVA prime-boost HIV-1 vaccine regimen
Material Type:
Article 		Add to My Research

Breadth, phenotype and functionality of Gag-specific T cell responses induced by a heterologous DNA/MVA prime-boost HIV-1 vaccine regimen

RETROVIROLOGY, 2012-09, Vol.9 (S2), p.P273-P273, Article P273 [Peer Reviewed Journal]

2012 Podola et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright ©2012 Podola et al; licensee BioMed Central Ltd. 2012 Podola et al; licensee BioMed Central Ltd. ;ISSN: 1742-4690 ;EISSN: 1742-4690 ;DOI: 10.1186/1742-4690-9-S2-P273

Full text available

Citations Cited by

Results 1 - 20 of 538  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (511)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1977  (26)
  2. 1977 To 1987  (87)
  3. 1988 To 1998  (187)
  4. 1999 To 2010  (160)
  5. After 2010  (79)
  6. More options open sub menu

Resource Type 

  1. Articles  (500)
  2. Conference Proceedings  (36)
  3. Images  (1)
  4. Reports  (1)
  5. More options open sub menu

Language 

  1. Japanese  (28)
  2. Russian  (5)
  3. Swedish  (4)
  4. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait